Adium
Clinical trials sponsored by Adium, explained in plain language.
-
Generic tamsulosin put to the test: are they truly equal?
Knowledge-focused CompletedThis study checks whether a test version of tamsulosin 0.4 mg prolonged-release tablets works the same as a reference version in healthy men aged 18 to 55. Participants take a single dose of each tablet on separate occasions after a meal, and researchers measure drug levels in th…
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Generic tamsulosin put to the test: will it match the brand?
Knowledge-focused CompletedThis trial investigates whether a test version of tamsulosin 0.4 mg prolonged-release tablets works the same as the reference product (Omnic Ocas) in healthy male volunteers. Thirty-four men aged 18 to 55 will receive single doses of each tablet under fasted conditions in a cross…
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Generic diabetes combo pill put to the test in healthy volunteers
Knowledge-focused CompletedThis completed study tested whether a new tablet containing empagliflozin and metformin works the same in the body as the reference drug Synjardy. Forty-two healthy adults took a single dose of each version under fed conditions. The goal was to check bioequivalence, meaning the t…
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Generic diabetes combo drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked whether a generic version of the diabetes drug empagliflozin/metformin is absorbed into the body the same way as the brand-name drug Synjardy. 42 healthy adults took a single dose of each tablet under fed conditions. The goal was to see if the two versions are …
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Diabetes drug showdown: are two pills equally effective?
Knowledge-focused CompletedThis study checked whether a generic version of a diabetes medication (Empagliflozin/Metformin) works the same as the brand-name version in healthy adults. 42 participants took a single dose of each pill under fed conditions, and researchers measured drug levels in the blood. The…
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Diabetes drug copycat put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a generic version of a diabetes combination pill (empagliflozin/metformin) works the same as the brand-name version in the body. 42 healthy adults took a single dose of each pill under fed conditions. The goal was to see if the two pills are bioequivalent, m…
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Healthy volunteers test generic vs. brand drug equivalence
Knowledge-focused CompletedThis study checked if two different oral versions of vortioxetine 20 mg tablets are absorbed the same way in the body. Twenty healthy adults aged 18 to 55 took a single dose of each version in a random order. The goal was to measure drug levels in the blood, not to treat any cond…
Phase: PHASE1 • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Generic diabetes pill matches brand in healthy volunteer test
Knowledge-focused CompletedThis study tested whether a generic version of empagliflozin (25 mg) works the same as the brand-name drug Jardiance® in 32 healthy adults. Participants took a single dose of each tablet under fasting conditions, and researchers measured drug levels in the blood to check for bioe…
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC